early management / therapy for all advanced HER2+ breast cancers / /
MedicalCondition
cancers / Cancer / triple-negative breast cancers / disease / BRCA-mutated breast cancer / HRD-high tumours / gBRCA-mutated cancers / Tumour / stomatitis / alopecia / metastatic breast cancer / HER2+ breast cancers / HER2-positive breast cancers / diarrhea / BRCAmutated cancers / HER2-overexpressing metastatic breast cancer / deficiency / human breast cancer / advanced breast cancer / breast cancer / significantly more neuropathy and febrile neutropenia / /HER2+ breast cancers / tumours / BRCA-mutated cancers / /
MedicalTreatment
chemotherapy / /
Organization
McGill University Health Centre / /
Person
Jamil Asselah / Victoria Mandilaras / Nathaniel Bouganim / /
landmarks Assessing carboplatin and everolimus Victoria Mandilaras, MD, Resident; Nathaniel Bouganim, MD, Medical Oncologist; Jamil Asselah, MD, Medical Oncologist, McGill University Health Centre and Breast Disease Sit